Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113444125A reveals high-ee ligand for alkaloid synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable supply chain reliability.
Patent CN118772067A reveals citrate salt crystallization for high-purity elagolix intermediates, offering cost reduction and scalable supply chain solutions.
Patent CN104557851B reveals a novel catalytic route for Eliglustat intermediates. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical partners.
Discover high-purity axial chiral 4-aryl alpha-carboline intermediates synthesized via novel NHC organocatalysis. Reliable supply chain solutions for pharmaceutical manufacturing.
Patent CN111943930B details a mild copper-catalyzed amidation route for Lasmiditan, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114380811A reveals a cost-effective synthesis of Lubaibailong using nickel-catalyzed reduction and Suzuki coupling, offering significant supply chain advantages.
Patent CN116813648A details a robust synthesis route for pharmaceutical intermediates. This process offers significant supply chain reliability and cost reduction advantages.
Patent CN101379046A reveals a novel convergent synthesis for taxanes like TPI287, offering improved yield and purity for reliable pharmaceutical intermediates supplier networks.
Novel 4'-azido-2'-fluoro nucleoside synthesis patent analysis for high-purity antiviral pharmaceutical intermediates manufacturing and supply chain optimization.
Discover the novel GCLE-based synthesis of Cefepime Hydrochloride avoiding halogenated solvents. High purity, scalable process for reliable API intermediate supply.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Optimized Venetoclax synthesis route offers higher yield and reduced environmental impact. Reliable supplier for scalable pharmaceutical intermediate manufacturing.
Novel method using phenylketene achieves 68-72% yield without racemization, offering significant cost reduction in pharmaceutical manufacturing for oncology APIs.
Patent CN113512026A reveals a high-yield synthesis route for Esomeprazole Sodium. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN119019267A reveals nickel-catalyzed ring opening for axial chiral compounds. Enables cost reduction and scalable supply for pharmaceutical intermediates manufacturing.
Advanced homogeneous phase process for DHEA acetate production improves yield to 85% and eliminates carcinogenic solvents, offering reliable pharmaceutical intermediate supply.
Patent CN114790151A reveals a cost-effective composite catalytic route for methyl 2-cyano-2-valproate, offering significant supply chain advantages for valproamide manufacturing.
This patent details a refined milrinone production method ensuring high purity and reduced pollution. It offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing partners.
Patent CN116143652A reveals a cost-effective route for afoxolaner intermediates. Achieve high purity and scalable production for veterinary pharmaceuticals with optimized chemistry.
Advanced synthetic route for 6'-N-ethyl gentamicin C1a impurity standard. Enhances etimicin sulfate quality control with high-purity manufacturing capabilities.